References
1. Visser E, De Bock GH, Kollen BJ, Meijerink M, Berger MY, Dekker JH. Systematic screening for urinary incontinence in older women: Who could benefit from it? Scand J Prim Heal Care. 2012;30:21–8.
2. Van Gerwen MAG, Schellevis FG, Lagro-Janssen ALM. Management of urinary incontinence in general practice: Data from the second Dutch national survey. J Eval Clin Pract. 2009;15(2):341–5.
3. Minassian VA, Yan X, Lichtenfeld MJ, Sun H, Stewart WF. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J. 2012; 23:1087-1093.
4. Damen-van Beek Z, Wiersma T. Practice guideline ‘Urinary incontinence in women’ from the Dutch College of General Practitioners. Ned Tijdschr Geneeskd. 2016;160:D674.
5. Abrams P, Andersson K-E, Apostolidis A, Birder L, Bliss D, Brubaker L, et al. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn. 2018 Sep;37(7):2271–2.
6. Wessels NJ, Hulshof L, Loohuis AMM, van Gemert-Pijnen L, Jellema P, van der Worp H BM. User experiences and preferences regarding an app for the treatment of urinary incontinence in adult women: a qualitative study. JMIR Mhealth Uhealth 2020;8(6):e17114.
7. Loohuis AMM, Wessels NJ, Dekker JH, van Merode NAM, Slieker-ten Hove MC, Kollen BJ, Berger MY, van der Worp H BM. App-based treatment for urinary incontinence non-inferior to care-as-usual in primary care. Results of a pragmatic, randomized controlled trial. Ann Fam Med. 2020;(In press).
8. Sjöström M, Umefjord G, Stenlund H, Carlbring P, Andersson G, Samuelsson E. Internet-based treatment of stress urinary incontinence: 1- and 2-year results of a randomized controlled trial with a focus on pelvic floor muscle training. BJU Int. 2015;116(6);955-964
9. Asklund I, Nyström E, Sjöström M, Umefjord G, Stenlund H, Samuelsson E. Mobile app for treatment of stress urinary incontinence: A randomized controlled trial. Neurourol Urodyn. 2017;36(5):1369–76.
10. Sjöström M, Umefjord G, Lindholm L, Samuelsson E. Cost-effectiveness of an Internet-based treatment program for stress urinary incontinence. Neurourol Urodyn. 2015;34(3):244–50.
11. Sjöström M, Lindholm L, Samuelsson E. Mobile app for treatment of stress urinary incontinence: A cost-effectiveness analysis. J Med Internet Res. 2017;1;19(5).
12. Loohuis AM, Wessels NJ, Jellema P, Vermeulen KM, Slieker-ten Hove MC, van Gemert-Pijnen JE, et al. The impact of a mobile application-based treatment for urinary incontinence in adult women: Design of a mixed-methods randomized controlled trial in a primary care setting. Neurourol Urodyn. 2018;37:2167–76.
13. van der Worp H, Loohuis AMM, Flohil IL, Kollen BJ, Wessels NJ, Blanker MH. Recruitment through media and general practitioners resulted in comparable samples in an RCT on incontinence. J Clin Epidemiol. 2020;1;119:85–91.
14. Bump R, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obs Gynecol. 1996;175(1):10–17.
15. Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: The ICIQ-UI SF versus the Incontinence severity index. Neurourol Urodyn. 2009;(28):411–5.
16. Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30.
17. Versteegh M, M. Vermeulen K, M. A. A. Evers S, de Wit GA, Prenger R, A. Stolk E. Dutch Tariff for the Five-Level Version of EQ-5D. Value Heal. 2016;19(4);343-352.
18. Nystrom E, Sjostrom M, Stenlund H, Samuelsson E. ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Neurourol Urodyn. 2015;34(8):747–51.
19. McClure NS, Sayah F Al, Ohinmaa A, Johnson JA. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes. Value Heal [Internet]. 2018;21(9):1090–7.
20. Vermeulen KM, Visser E, Messelink EJ, Schram AJ, Berger MY, de Bock GH DJ. Cost-effectiveness of a pro-active approach of urinary incontinence in women. BJOG An Int J Obstet Gynaecol. 2016;123(7):1221.
21. Zorginstituut Nederland. Guideline for conducting economic evaluations in healthcare [in Dutch: Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg]. 2016.
22. Loohuis A, Chavannes N. Medical apps; Care for the future? [Dutch]. Huisarts Wet. 2017;60:440–3.
23. ALEA software for randomization in clinical trials. http://tenalea.net/Documents/ALEA/ALEARandomizationProgramFeatures.pdf.
24. Drummond, M.E., Sculpher, M.J., Torrance G. Methods for The Economic Evaluation of Health Care Programmes. 3rd edition. Oxford, UK: Oxford University Press; 2005
25. Ivankova N V., Creswell JW, Stick SL. Using Mixed-Methods Sequential Explanatory Design: From Theory to Practice. Field methods. 2006;18(1):3–20.